Yudi Zhang

Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms.

Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms.

Journal: Blood cancer journal

Published: February 04, 2026

Genetic and Clinical Features in TP53-Mutated Patients With Myelodysplastic Neoplasms: A Retrospective Study Based on Next-Generation Sequencing Data.

Genetic and Clinical Features in TP53-Mutated Patients With Myelodysplastic Neoplasms: A Retrospective Study Based on Next-Generation Sequencing Data.

Journal: Cancer reports (Hoboken, N.J.)

Published: October 15, 2025

Nuclear OXCT1 attenuates histone β-hydroxybutyrylation-mediated MHC-I transcription.

Nuclear OXCT1 attenuates histone β-hydroxybutyrylation-mediated MHC-I transcription.

Journal: Nature chemical biology

Published: July 09, 2025

The molecular prognostic scoring system for normal karyotype myelodysplastic syndromes.

The molecular prognostic scoring system for normal karyotype myelodysplastic syndromes.

Journal: Journal of translational medicine

Published: October 19, 2024

Moderate-To-Severe Bone Marrow Fibrosis Is an Independent Risk Factor For Myelodysplastic Neoplasms Patients With Increased Blasts.

Moderate-To-Severe Bone Marrow Fibrosis Is an Independent Risk Factor For Myelodysplastic Neoplasms Patients With Increased Blasts.

Journal: Hematological oncology

Published: July 25, 2024

Proteomic and lipidomic analysis of the mechanism underlying astragaloside IV in mitigating ferroptosis through hypoxia-inducible factor 1α/heme oxygenase 1 pathway in renal tubular epithelial cells in diabetic kidney disease.

Proteomic and lipidomic analysis of the mechanism underlying astragaloside IV in mitigating ferroptosis through hypoxia-inducible factor 1α/heme oxygenase 1 pathway in renal tubular epithelial cells in diabetic kidney disease.

Journal: Journal of ethnopharmacology

Published: April 05, 2024

The m6A methyltransferase METTL14 promotes cell proliferation via SETBP1-mediated activation of PI3K-AKT signaling pathway in myelodysplastic neoplasms.

The m6A methyltransferase METTL14 promotes cell proliferation via SETBP1-mediated activation of PI3K-AKT signaling pathway in myelodysplastic neoplasms.

Journal: Leukemia

Published: October 07, 2023

Mutation landscape of normal karyotype myelodysplastic syndromes and their prognostic impact.

Mutation landscape of normal karyotype myelodysplastic syndromes and their prognostic impact.

Journal: American journal of hematology

Published: September 20, 2023

The pentraxin family in autoimmune disease.

The pentraxin family in autoimmune disease.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: August 22, 2023

The der(1;7)(q10;p10) defining a distinct profile from -7/del(7q) in myelodysplastic syndromes: A systematic review and meta-analysis.

The der(1;7)(q10;p10) defining a distinct profile from -7/del(7q) in myelodysplastic syndromes: A systematic review and meta-analysis.

Journal: Cancer medicine

Published: July 31, 2023

Tetrandrine enhances antitumor effects of the histone deacetylase inhibitor MS-275 in human cancer in a Bax- and p53-dependent manner.

Tetrandrine enhances antitumor effects of the histone deacetylase inhibitor MS-275 in human cancer in a Bax- and p53-dependent manner.

Journal: European journal of pharmacology

Published: February 10, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026